Hideaki Moriwaki

3.4k citations

24 papers · 2.8k indexed · 1 hit paper · h-index 16

Co-authors: Noriaki Kume Toru Kita Tatsuya Sawamura Τοmoh Masaki Takuma Aoyama Hajime Hoshikawa Takeshi Tanaka Soichi Miwa
Topics: Atherosclerosis and Cardiovascular Diseases (17 papers)Inflammatory mediators and NSAID effects (6 papers)Antioxidant Activity and Oxidative Stress (5 papers)
Cited by: Immunology Biochemistry Immunology and Allergy
Journals: Nature Circulation Circulation Research
Partner nations: Japan United States

In The Last Decade

Hideaki Moriwaki

24 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An endothelial receptor for oxidized low-density lipoprotein

1997 1.1k citations Tatsuya Sawamura, Noriaki Kume et al. Nature profile →

Peers

Countries citing papers authored by Hideaki Moriwaki

Since Specialization

Citations

This map shows the geographic impact of Hideaki Moriwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Moriwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Moriwaki more than expected).

Fields of papers citing papers by Hideaki Moriwaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Moriwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Moriwaki. The network helps show where Hideaki Moriwaki may publish in the future.

Co-authorship network of co-authors of Hideaki Moriwaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Moriwaki. A scholar is included among the top collaborators of Hideaki Moriwaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Moriwaki. Hideaki Moriwaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment 2016 ·European Journal of Clinical Pharmacology ·Keita Hirai,(unknown),Hideaki Moriwaki,(unknown),(unknown),Daiki Tsuji,Kazuyuki Inoue,(unknown),Kunihiko Itoh	16
2	Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy 2015 ·Thrombosis Research ·Keita Hirai,Yuto Yamada,Hideki Hayashi,Masaki Tanaka,(unknown),Masayuki Suzuki,(unknown),Hideaki Moriwaki,Takehide Akimoto,Daiki Tsuji,Kazuyuki Inoue,Kunihiko Itoh	13
3	Effect of VKORC1 –1639 G>A polymorphism, body weight, age, and serum albumin alterations on warfarin response in Japanese patients 2009 ·Thrombosis Research ·(unknown),Hideki Hayashi,(unknown),(unknown),Hideaki Moriwaki,Takehide Akimoto,Osamu Doi,(unknown),(unknown),Kazuyuki Inoue,Kunihiko Itoh	54
4	Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death 2004 ·Circulation ·Aaron E. Cozen,Hideaki Moriwaki,(unknown),Mary Beth DeYoung,Helén L. Dichek,(unknown),Stephen G. Young,Murielle M. Véniant,David A. Dichek	77
5	Overexpression of Urokinase by Macrophages or Deficiency of Plasminogen Activator Inhibitor Type 1 Causes Cardiac Fibrosis in Mice 2004 ·Circulation Research ·Hideaki Moriwaki,April Stempien‐Otero,(unknown),Aaron E. Cozen,David A. Dichek	103
6	Role of Oxidized LDL in Atherosclerosis 2001 ·Annals of the New York Academy of Sciences ·(unknown),Noriaki Kume,Manabu Minami,Kazutaka Hayashida,Toshinori Murayama,Hideto Sano,Hideaki Moriwaki,Hiroshi Kataoka,Eiichiro Nishi,Hisanori Horiuchi,Hidenori Arai,Masayuki Yokode	220
7	Oxidized‐LDL and Atherosclerosis: Role of LOX‐1 2000 ·Annals of the New York Academy of Sciences ·(unknown),Noriaki Kume,Masayuki Yokode,Kenji Ishii,Hidenori Arai,Hisanori Horiuchi,Hideaki Moriwaki,Manabu Minami,Hiroharu Kataoka,Yoshio Wakatsuki	40
8	Germline Incorporation of a Replication-Defective Adenoviral Vector in Mice Does Not Alter Immune Responses to Adenoviral Vectors 2000 ·Molecular Therapy ·Fernando D. Camargo,(unknown),Aloke V. Finn,(unknown),Aaron E. Cozen,Hideaki Moriwaki,Darren B. Schneider,Ramtin Agah,David A. Dichek	5
9	Expression of Lectin‐like Oxidized LDL Receptor‐1 in Human Atherosclerotic Lesions 2000 ·Annals of the New York Academy of Sciences ·Hiroharu Kataoka,Noriaki Kume,Manabu Minami,Hideaki Moriwaki,Tatsuya Sawamura,Τοmoh Masaki,Toru Kita	8
10	Lysophosphatidylcholine phosphorylates CREB and activates the jun2TRE site of c‐jun promoter in vascular endothelial cells 1999 ·FEBS Letters ·Yasushi Ueno,Noriaki Kume,Susumu Miyamoto,(unknown),Hiroharu Kataoka,Hiroshi Ochi,Eiichiro Nishi,Hideaki Moriwaki,Manabu Minami,Nobuo Hashimoto,Toru Kita	17
11	Expression of Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 in Human Atherosclerotic Lesions 1999 ·Circulation ·Hiroharu Kataoka,Noriaki Kume,Susumu Miyamoto,Manabu Minami,Hideaki Moriwaki,Takatoshi Murase,Tatsuya Sawamura,Τοmoh Masaki,Nobuo Hashimoto,Toru Kita	378
12	IS105 Inducible expression of LOX-1, a novel receptor for oxidized low density lipoprotein in vascular endothelial cells 1998 ·Japanese Circulation Journal-english Edition ·Noriaki Kume,Hideaki Moriwaki,Tatsuya Sawamura,Τοmoh Masaki,Toru Kita	6
13	Expression of lectin‐like oxidized low density lipoprotein receptor‐1 in human and murine macrophages: upregulated expression by TNF‐α 1998 ·FEBS Letters ·Hideaki Moriwaki,Noriaki Kume,Hiroharu Kataoka,Takatoshi Murase,Eiichiro Nishi,Tatsuya Sawamura,Τοmoh Masaki,Toru Kita	127
14	Inducible Expression of Lectin-like Oxidized LDL Receptor-1 in Vascular Endothelial Cells 1998 ·Circulation Research ·Noriaki Kume,Takatoshi Murase,Hideaki Moriwaki,Takuma Aoyama,Tatsuya Sawamura,Τοmoh Masaki,Toru Kita	260
15	Tyrosine Phosphorylation of Platelet Endothelial Cell Adhesion Molecule-1 Induced by Lysophosphatidylcholine in Cultured Endothelial Cells 1998 ·Biochemical and Biophysical Research Communications ·Hiroshi Ochi,Noriaki Kume,Eiichiro Nishi,Hideaki Moriwaki,Michitaka Masuda,Keigi Fujiwara,(unknown)	17
16	Ligand Specificity of LOX-1, a Novel Endothelial Receptor for Oxidized Low Density Lipoprotein 1998 ·Arteriosclerosis Thrombosis and Vascular Biology ·Hideaki Moriwaki,Noriaki Kume,Tatsuya Sawamura,Takuma Aoyama,Hajime Hoshikawa,Hiroshi Ochi,Eiichiro Nishi,Τοmoh Masaki,Toru Kita	159
17	Ligand specificity of LOX-1, a novel receptor for oxidized low density lipoprotein 1997 ·Atherosclerosis ·Hideaki Moriwaki,Noriaki Kume,Tatsuya Sawamura,Shigekazu Itokawa,Hajime Hoshikawa,Takuma Aoyama,Yasushi Ueno,Eiichiro Nishi,Τοmoh Masaki,Toru Kita	7
18	Lysophosphatidylcholine Induces Heparin‐Binding Epidermal Growth Factor‐like Growth Factor and Interferon‐γ in Human T‐Lymphocytes 1997 ·Annals of the New York Academy of Sciences ·Eiichiro Nishi,Noriaki Kume,Hiroshi Ochi,Hideaki Moriwaki,Shigeki Higashiyama,Naoyuki Taniguchi,Toru Kita	5
19	An endothelial receptor for oxidized low-density lipoproteinbreakdown → 1997 ·Nature ·Tatsuya Sawamura,Noriaki Kume,Takuma Aoyama,Hideaki Moriwaki,Hajime Hoshikawa,Yuichi Aiba,Takeshi Tanaka,Soichi Miwa,Yoshimoto Katsura,Toru Kita,Τοmoh Masaki	1137
20	Lysophosphatidylcholine Increases Expression of Heparin-Binding Epidermal Growth Factor–Like Growth Factor in Human T Lymphocytes 1997 ·Circulation Research ·Eiichiro Nishi,Noriaki Kume,Hiroshi Ochi,Hideaki Moriwaki,Yoshio Wakatsuki,Shigeki Higashiyama,Naoyuki Taniguchi,Toru Kita	31

About Hideaki Moriwaki

Hideaki Moriwaki is a scholar working on Biochemistry, Immunology and Immunology and Allergy, having authored 24 papers that have together received 2.8k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (17 papers), Inflammatory mediators and NSAID effects (6 papers) and Antioxidant Activity and Oxidative Stress (5 papers). The work is most often cited by research in Immunology (1.9k citations), Biochemistry (365 citations) and Immunology and Allergy (258 citations). Hideaki Moriwaki has collaborated with scholars based in Japan and United States. Frequent co-authors include Noriaki Kume, Toru Kita, Tatsuya Sawamura, Τοmoh Masaki, Takuma Aoyama, Hajime Hoshikawa, Takeshi Tanaka, Soichi Miwa, Yoshimoto Katsura and Yuichi Aiba. Their work appears in journals such as Nature, Circulation and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact